TP53 and urinary bladder cancer: Additionally, pathway enrichment analysis revealed significant upregulation of certain oncogenic pathways, including PI3K/AKT, Notch, p53, and mTOR signaling pathways in PDOs.[14] These findings suggest that our PDOs possess pronounced tumor characteristics, indicating their potential to be valuable models for bladder cancer research (Figure 2G).